Affiliation:
1. State Research Centre for Preventive Medicine, Moscow
Abstract
Hypercholesterolemia (HCH) and vascular inflammation are the main therapeutic targets in atherosclerosis. The paper discusses the results of the studies which have focussed on the effects of a new class of physiologically active substances (polyprenols and β-sitosterols) on lipid profile and pro-inflammatory cytokines in HCH patients with low to moderate cardiovascular risk. Polyprenol phosphates and phytosterols could help to achieve significant changes in lipid profile and normalisation of immunologic parameters.
Subject
Cardiology and Cardiovascular Medicine
Reference10 articles.
1. Dawber TR. The Framingham Study: The Epidemiology of Atherosclerotic Disease. Cambridge, MA: Harvard Univ Pr; 1980.
2. Verschuren WMM, Jacobs DR, Bloemberg BPM, et al. Semm total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five-year follow-up of the Seven Countries study. JAMA 1995; 274: 131–6.
3. ESC/EAS Guidelines for the management of dyslipidemia. The Task Force of the management of dyslipidemias of the European Society of Cardiology (ESC) and the European Society of Atherosclerosis (EAS). Rathional Pharmacotherapy in Cardiology 2012. Add № 1. Russian (Rekomendatsii Evropeiskogo obshchestva kardiologov i Evropeiskogo obshchestva ateroskleroza po lecheniyu dislipidemii. Ratsional'naya Farmakoterapiya v Kardiologii 2012; prilozhenie № 1).
4. Diagnosis and treatment of dyslipidemia in the prevention and management of atherosclerosis. Russian Recommendations, V Revision. Moscow 2012. Russian Cardiologicaj J 2012; 4 (96). Russian (Diagnostika i korrektsiya narushenii lipidnogo obmena s tsel'yu profilaktiki i lecheniya ateroskleroza. Rossiiskie rekomendatsii. V peresmotr. Moskva 2012 god. Rossiiskii kardiologicheskii zhurnal 2012; 4 (96). Prilozhenie 1).
5. Oganov RG, Kukharchuk VV, Arutyunov GP, et al. Persistent dyslipidemia in statin-treated patients: Russian real-world clinical practice data (Russian part of the DYSIS Study). Cardiovascular Therapy and Prevention 2012;11 (4):70–8. Russian (Oganov R. G., Kukharchuk V. V., Arutyunov G. P. i dr. Cokhranyayushchiesya narusheniya pokazatelei lipidnogo spektra u patsientov s dislipidemiei, poluchayushchikh statiny, v real'noi klinicheskoi praktike v Rossiiskoi Federatsii (rossiiskaya chast' issledovaniya DYSIS). Kardiovaskulyarnaya terapiya i profilaktika 2012; 11 (4): 70–8).